The search for a better way to fight cancer is unfolding quietly against the floor-to-ceiling window of a conference room in a San Francisco office building where three young men are scrutinizing a jumble of Post-it Notes. Each yellow stickie is etched with meticulously drawn boxes and text in tiny black print. After a few minutes of contemplation, the men start placing blue-dot stickers -- one here, one there -- atop the notes. Each dot represents a vote in favor of a particular layout or wording, and each helps the trio converge on a new prototype for the online app of a company called Foundation Medicine (FMI). The goal: to make it easier for the doctors who use the app to record findings on new drug therapies. Foundation, a fast-growing company based in Cambridge, Mass., offers a diagnostic test that uses DNA sequencing to help doctors decide which drugs to use to fight a specific tumor. After a September IPO, it is now worth more than $600 million. For this two-day "design sprint" to make its app easier to use, Foundation came to Google Ventures.
Where Google Ventures is pinning its hopes - Dec. 19, 2013
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.